Compare ALEMBIC with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs FABINO LIFE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC FABINO LIFE ALEMBIC/
FABINO LIFE
 
P/E (TTM) x 18.7 - - View Chart
P/BV x 0.7 4.0 17.4% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ALEMBIC   FABINO LIFE
EQUITY SHARE DATA
    ALEMBIC
Mar-21
FABINO LIFE
Mar-21
ALEMBIC/
FABINO LIFE
5-Yr Chart
Click to enlarge
High Rs123NA-   
Low Rs32NA-   
Sales per share (Unadj.) Rs2.925.5 11.2%  
Earnings per share (Unadj.) Rs0.50.3 215.6%  
Cash flow per share (Unadj.) Rs0.70.4 180.6%  
Dividends per share (Unadj.) Rs0.200-  
Avg Dividend yield %0.30- 
Book value per share (Unadj.) Rs89.510.9 823.8%  
Shares outstanding (eoy) m256.781.20 21,398.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x27.00-   
Avg P/E ratio x143.50-  
P/CF ratio (eoy) x111.70-  
Price / Book Value ratio x0.90-  
Dividend payout %37.10-   
Avg Mkt Cap Rs m19,8680-   
No. of employees `000NANA-   
Total wages/salary Rs m2261 16,025.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m73531 2,404.1%  
Other income Rs m1090 545,800.0%   
Total revenues Rs m84431 2,760.2%   
Gross profit Rs m1041 16,550.8%  
Depreciation Rs m390 24,625.0%   
Interest Rs m40 5,171.4%   
Profit before tax Rs m1700 39,630.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m320 26,666.7%   
Profit after tax Rs m1380 46,136.7%  
Gross profit margin %14.22.1 684.1%  
Effective tax rate %18.828.8 65.1%   
Net profit margin %18.81.0 1,906.5%  
BALANCE SHEET DATA
Current assets Rs m1,02120 5,056.7%   
Current liabilities Rs m5946 10,705.4%   
Net working cap to sales %58.147.9 121.3%  
Current ratio x1.73.6 47.2%  
Inventory Days Days10,1918 133,409.6%  
Debtors Days Days6861,585 43.3%  
Net fixed assets Rs m23,0692 1,034,470.0%   
Share capital Rs m51412 4,279.7%   
"Free" reserves Rs m22,4571 2,180,264.1%   
Net worth Rs m22,97013 176,287.6%   
Long term debt Rs m03 0.0%   
Total assets Rs m24,09022 107,447.0%  
Interest coverage x48.17.0 686.8%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x01.4 2.2%   
Return on assets %0.61.6 35.9%  
Return on equity %0.62.3 26.0%  
Return on capital %0.83.1 24.8%  
Exports to sales %1.50-   
Imports to sales %6.10-   
Exports (fob) Rs m11NA-   
Imports (cif) Rs m45NA-   
Fx inflow Rs m110-   
Fx outflow Rs m450-   
Net fx Rs m-340-   
CASH FLOW
From Operations Rs m-22-5 484.9%  
From Investments Rs m-347-1 36,955.3%  
From Financial Activity Rs m-1544 -3,483.4%  
Net Cashflow Rs m-523-1 50,758.3%  

Share Holding

Indian Promoters % 70.9 56.8 124.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.8 0.0 -  
FIIs % 1.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 43.2 67.4%  
Shareholders   80,135 195 41,094.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Tanks 750 Points as Energy, Auto Stocks Fall; Reliance, ONGC & Titan Top Losers(10:30 am)

Asian share markets erased early gains and fell in the negative territory tracking a sharp fall on Wall Street.

Related Views on News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

How to Find the Next Multibagger Stock in the Market(Profit Hunter)

Jun 17, 2022

The #1 make or break factor in your portfolio you shouldn't ignore.

Is the Market Correction Over?(Fast Profits Daily)

Jun 17, 2022

In this video I'll show you why I think the market correction could be coming to an end.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Jul 1, 2022 01:28 PM

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS